Intrinsic Value of S&P & Nasdaq Contact Us

Tilray Brands, Inc. TLRY NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
47/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+43.9%

Tilray Brands, Inc. (TLRY) reported total assets of $2.07B and total liabilities of $549.12M for quarter ending 2026-02-28, resulting in total equity of $1.53B.

The company held $219.93M in cash and short-term investments. Total debt stood at $219.98M, with net debt of $15.36M. The Debt-to-Equity (D/E) ratio was 0.14 (conservative).

Current ratio is 2.79, indicating strong short-term liquidity.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (47/100) — Total assets $2.07B and equity $1.53B support the company's competitive scale
  • VALUE (96/100) — Debt-to-Equity 0.14 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 47/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
96/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
47/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Tilray Brands, Inc. Balance Sheet History
Metric Q3 FY2026 Q2 FY2026 Q1 FY2026 Q4 FY2025
Total Assets $2.07B$2.93B$2.86B$2.9B
Total Liabilities $549.12M$771.26M$771.97M$860.49M
Total Debt $219.98M$446.52M$444.71M$451.09M
Cash & Investments $219.93M$407.29M$363.78M$351.78M
Total Stockholders Equity $1.56B$2.21B$2.12B$2.07B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message